Johnson & Johnson Pauses COVID Vaccine Trials After ‘Unexplained Illness’ By Jeremy Loffredo OCTOBER 14, 2020 Johnson & Johnson temporarily paused Phase 3 clinical trials of its COVID-19 vaccine on Monday after one participant experienced what the company termed “an unexplained illness.” The multinational maker of packaged consumer goods, medical devices and ...